Start-up Innovation in MedTech : Micropump Drug Delivery Technology

Friday, September 20
11:10am to 11:30am

Abstract :

MicroMED Co., Ltd. owns a novel and powerful bio-MEMS (Biomedical MicroElectroMechanical Systems) micropump platform technology. MicroMED’s proprietary MEMS platform technology provides a flexible customization service for wide variety of drug delivery applications (from implantable to wearable devices, animal to human, small (mm) to large (cm) device footprint, slow (nL/Hr) to fast (mL/sec) delivery rate, small dose (pg) to large dose (g), small molecule to biologics drug compatibility, and 510k to 505b2 regulatory paths).  Our product, service, and business model are very flexible (in design, prototyping, manufacturing, quantity of order, speed to the market, small team to large project, and academia to biopharma customers) with a full product spectrum to meet our pharmaceutical customers’ needs for their drug delivery applications.

Share page with AddThis